Viremia, Resuppression, and Time to Resistance in Human Immunodeficiency Virus (HIV) Subtype C during First‐Line Antiretroviral Therapy in South Africa | Zendy

Christopher J. Hoffmann | Zendy; Salome Charalambous | Zendy; John Sim | Zendy; Joanna Ledwaba | Zendy; Graham Schwikkard | Zendy; Richard E. Chaisson | Zendy; Katherine Fielding | Zendy; Gavin Churchyard | Zendy; Lynn Morris | Zendy; Alison D. Grant | Zendy

Open Access

Viremia, Resuppression, and Time to Resistance in Human Immunodeficiency Virus (HIV) Subtype C during First‐Line Antiretroviral Therapy in South Africa

Author(s) -

Christopher J. Hoffmann,

Salome Charalambous,

John Sim,

Joanna Ledwaba,

Graham Schwikkard,

Richard E. Chaisson,

Katherine Fielding,

Gavin Churchyard,

Lynn Morris,

Alison D. Grant

Publication year - 2009

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/648444

Subject(s) - viremia , antiretroviral therapy , virology , human immunodeficiency virus (hiv) , cart , medicine , viral load , immunology , geography , archaeology

Episodes of viremia are common in African antiretroviral therapy (ART) programs. We sought to describe viremia, resuppression, and accumulation of resistance during first-line combination ART (cART) in South Africa.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research